
NASDAQ:PEP
This summary was created by AI, based on 10 opinions in the last 12 months.
PepsiCo faces significant challenges, particularly from the emerging GLP-1 weight loss drugs, which are impacting its snack sales and overall demand in North America. Recent reports show that while the company has a robust dividend yield of 4% and has historically performed well due to its strong snack portfolio like Frito-Lay, the current market dynamics have led to a lackluster performance, with a year-to-date decline in stock value compared to competitors like Coke. Despite being downgraded and facing a weakening North American consumer, some experts see potential in the stock if it falls further, labeling it as a buying opportunity. Analysts are divided on its valuation, with opinions suggesting it could be undervalued or fairly valued, reinforcing a cautious approach among investors as they await the upcoming earnings report, which could give clearer insights into its future potential.
He expects a great report from them on Thursday, because their snack business given them more consumer exposure than Coke has. Their last quarter was fine, but the market yawn from being bored with consumer staples. He bets their business is accelerating.
Allan Tong’s Discover Picks Analysts such as Jim Cramer would buy Pepsi stock now as the number of Covid cases could rise as the weather turns colder and more people stay at home to snack. Analysts expects its EPS to reach $1.50, which would return to last year’s levels. Pepsi pays a dividend just under 3%. The trailing PE has ballooned from 15.62x last December to the current 26.85x, which will give some investors pause. Read PEP and NVDA: 3 More Top Recognized ESG Investing Options for our full analysis.